Treatment of Refractory Urinary Retention Secondary to Benign Prostatic Hyperplasia (BPH) With Dual Five Alpha Reductase Inhibition Combined With an Alpha Blocker

Clinical trial NCT00680680 · COMPLETED

Trial details

NCT number: NCT00680680
Sponsor: Franklin D. Gaylis, MD Inc.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Urinary Retention Benign Prostatic Hyperplasia

Start date: 2004-05-01
Primary completion: 2008-02-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.